Stay updated on Immunotherapy Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combo in Pancreatic Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to include new information about the GVAX Pancreas Vaccine and CRS-207, along with a revision update to v2.15.0. Notably, the previous study details regarding nivolumab and ipilimumab have been removed.SummaryDifference23%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Immunotherapy Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combo in Pancreatic Cancer Clinical Trial page.